Biosimulation Market's Remarkable 21.5% CAGR Journey to US$ 20.9 Billion by 2032 | FMI Reveals
The global Biosimulation Market, which was valued at around US$ 2.6 billion in 2021, is anticipated to grow at a CAGR of 21.5% during the ensuing ten years, reaching US$ 20.9 billion by the end of 2032. The necessity to develop novel pharmaceuticals to treat rising ailments will be what will fuel the demand for bios...
Source: pharmiweb.com